BioSpace News Archive

Point of care coagulation or POC coagulation testing analyzers measures the prothrombin time.

ASLAN Pharmaceuticals, a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative treatments to transform the lives of patients, announced further progress towards a primary listing on the Nasdaq Global Market and receipt of a Notice of Delisting from the Taipei Exchange, an expected step in the TPEx delisting process.

Mirikizumab met the primary and all key secondary endpoints versus placebo at Week 16 and all key secondary endpoints versus Cosentyx® (secukinumab) at Week 16 and Week 52, including superiority in skin clearance at Week 52

Sensient Technologies Corporation reported diluted earnings per share of 72 cents in the second quarter of 2020 compared to diluted earnings per share of 81 cents in the second quarter of 2019.

TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) (“TerrAscend” or the “Company”) today announced that it will host a Virtual Investor and Analyst Day on Thursday, August 6, 2020 from 10:00 AM to approximately 12:00 PM ET.

MAA is for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma, primary mediastinal B-cell lymphoma and follicular lymphoma grade 3B

Cigna Corporation issued a statement on systemic racism and a commitment to equity and equality

First data to read out from the Janssen and MeiraGTx collaboration Johnson & Johnson to review interim Phase 1/2 clinical trial findings in pre-recorded webcast Company anticipates progressing the program to Phase 3

Denovo Biopharma LLC, a pioneer in applying precision medicine to development of innovative therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for DB102 (enzastaurin) being de

Liminal BioSciences Inc. (Nasdaq: LMNL) (TSX: LMNL) (“Liminal BioSciences” or the “Company”), a clinical-stage biopharmaceutical company, announced today that it has acquired all of the issued and outstanding shares in the capital of Fairhaven Pharmaceuticals Inc. (" Fairhaven "), thu